Current:Home > ContactMeghan McCain Says She Was Encouraged to Take Ozempic After Giving Birth to Daughter Clover -WealthX
Meghan McCain Says She Was Encouraged to Take Ozempic After Giving Birth to Daughter Clover
View
Date:2025-04-22 05:46:42
Meghan McCain is sharing her point of view on the drug Ozempic.
One month after welcoming her second daughter, Clover, with husband Ben Domenech, the View alum says she's "really astonished" by how many people have suggested she use the medication as a means of weight loss.
"In case you're unaware, there is a craze sweeping the nation: a new 'miracle' drug," Meghan wrote in a personal essay penned for the Daily Mail Feb. 23. "One injection, once a week, for a cool $1,000 a pop, and you can just melt the pounds away."
Noting the popularity of the medication—which is usually prescribed for diabetics—in Hollywood, the 38-year-old went on to name a few celebrities that have discussed their knowledge of the drug, including Chelsea Handler, who recently said she "didn't even know" she was taking it.
"Ozempic also seems to be the hottest thing in the media industry," Meghan continued. "So many of the men and women you see on TV every day are rumored to be using the drug."
As the commentator—who also shares 2-year-old daughter Liberty with Ben—noted, she was also "astonished" at how many people personally brought up using the medication to her.
"I'm told 'everyone is doing it,' as if that was ever a compelling case," Meghan wrote. "I hear 'just take the shot', as it has become known in shorthand. I was even offered a black-market freebie by someone with 'extra shots at home.' Well, let me make one thing very clear. I'm not taking it. I refuse."
And she says she sees a "clear moral issue" with the drug's popularity and the concept that medication can be a quick weight-loss solution—especially after having a baby.
"I am realistic about how long it takes to have your body feel normal again post-baby," she noted. "So, don't rush me!"
Meghan also reflected on why this topic goes beyond just her.
"As a new mother, I also have a responsibility to set an example for my daughters, who will one day face the same beauty standards," she added. "Their world will only be more challenging as social media seeps more deeply into the American mind. This is not the world I want for them and not the world I want for myself."
In a statement previously shared to E! News, a rep for Novo Nordisk, the pharmaceutical company that makes Ozempic, said the drug is "not approved for chronic weight management."
"While we recognize that some healthcare providers may be prescribing Ozempic for patients whose goal is to lose weight, Novo Nordisk does not promote, suggest, or encourage off-label use of our medicines and is committed to fully complying with all applicable US laws and regulations in the promotion of our products," their statement read. "We trust that healthcare providers are evaluating a patient's individual needs and determining which medicine is right for that particular patient."
For the latest breaking news updates, click here to download the E! News AppveryGood! (6)
Related
- 'Most Whopper
- Los Angeles County to pay $5M settlement over arrest of election technology company founder
- A fire in China’s Jiangxi province kills at least 25 people, local officials say
- Britain says it has no plans for conscription, after top general says the UK may need a citizen army
- Can Bill Belichick turn North Carolina into a winner? At 72, he's chasing one last high
- Alabama inmate waiting to hear court ruling on scheduled nitrogen gas execution
- The death toll from a small plane crash in Canada’s Northwest Territories is 6, authorities say
- A Texas school’s punishment of a Black student who wears dreadlocks is going to trial
- Senate begins final push to expand Social Security benefits for millions of people
- January's full moon rises Thursday: What to know about the 'wolf moon'
Ranking
- Appeals court scraps Nasdaq boardroom diversity rules in latest DEI setback
- Death toll in southwestern China landslide rises to 34 and 10 remain missing
- Americans’ economic outlook brightens as inflation slows and wages outpace prices
- Brewers agree to terms with former Phillies first baseman Rhys Hoskins, per report
- Intellectuals vs. The Internet
- UK’s flagship nuclear plant could cost up to $59 billion, developer says
- UN court to issue ruling Friday on South Africa’s request for order to halt Israel’s Gaza offensive
- Save Up to 72% Off on Cult-Fave Peter Thomas Roth Essentials That Will Transform Your Skincare Routine
Recommendation
Why we love Bear Pond Books, a ski town bookstore with a French bulldog 'Staff Pup'
2 hospitals and 19 clinics will close in western Wisconsin, worrying residents and local officials
Boeing's quality control draws criticism as a whistleblower alleges lapses at factory
Trial of Land Defenders Fighting the Coastal GasLink Pipeline is Put on Hold as Canadian Police Come Under Scrutiny for Excessive Force
What do we know about the mysterious drones reported flying over New Jersey?
Daniel Will: How the Business Wealth Club Selects Investment Platforms
UN court to issue ruling Friday on South Africa’s request for order to halt Israel’s Gaza offensive
Customers eligible for Chick-fil-A's $4.4 million lawsuit settlement are almost out of time